Motor Neurone Disease Trial, Recruiting NCT03827187 Sponsor: University of Ulster Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT03827187
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Study 1 – Initial Assessment/Screening

  • People who have been diagnosed with a disorder of consciousness or a low awareness state — this includes unclear diagnoses in low awareness states, vegetative state, or minimally conscious state
  • People with locked-in syndrome or completed locked-in syndrome caused by injury or disease (for example, motor neuron disease), provided they do not have health problems that would prevent participation — these individuals would be assessed as a separate group from those with low awareness states
  • People who are in the acute or post-acute stage of their condition, where appropriate

Study 2 – Brain-Computer Interface (BCI) Training

  • People identified in Study 1 as showing some level of awareness, based on observed brain activity responses
  • People who are known to have awareness but are considered suitable candidates for devices and technologies controlled by brain signals (brain-computer interfaces) that do not require physical movement

Who may not be able to join:

Study 1 – Initial Assessment/Screening

  • People who have brain-related diseases or conditions — such as a progressive neurological condition or uncontrolled epilepsy — or who experience pain, if the clinical team determines these factors would interfere with brain data or make participation unsuitable
  • People who are currently taking medications that cause significant tiredness or affect thinking and mental functioning
  • People whose first language is not English
  • People who have significant uncontrollable movements of the arms or head, or who grind their teeth, as this can affect the quality of brain signal recordings

Study 2 – Brain-Computer Interface (BCI) Training

  • People whose Study 1 results showed no active brain responses — where there was no measurable difference from baseline activity (confirm with trial site for full details, as the source criteria appear incomplete)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Damien Coyle, PhD, University of Ulster

Phone: +44 28 7167 5170

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Ulster
Registry
ClinicalTrials.gov
Start date
8 February 2022
Est. completion
1 August 2026

Where this trial is recruiting

🇮🇪 Ireland 🇬🇧 United Kingdom

Primary endpoints

Change in performance accuracy of BCI use pre- and post- training; Change in ability to use imagined movements to consistently communicate yes-no responses to closed questions over multiple sessions by participant with Prolonged Disorder of Consciousness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov